Esperion Therapeutics
ESPR
#6663
Rank
C$1.16 B
Marketcap
C$4.53
Share price
0.00%
Change (1 day)
33.22%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): C$0.10 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.41 Billion. In 2025 the company made an earning of C$90.88 Million, an increase over its 2024 earnings that were of C$10.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.10 B19.19%
2025 C$90.88 M749.49%
2024 C$10.69 M-104.99%
2023 -C$0.22 Billion-15.03%
2022 -C$0.26 Billion-20.61%
2021 -C$0.32 Billion84.28%
2020 -C$0.18 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.29 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$70.23 Million36.45%
2014 -C$51.47 Million43.55%
2013 -C$35.86 Million145.26%
2012 -C$14.62 Million
2002 -C$41.68 Million-7.81%
2001 -C$45.21 Million15.03%
2000 -C$39.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.84 B 8,600.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.36 B 6,407.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.73 Billion-736.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$87.12 Million-176.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.27 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.21 B 87.82%๐Ÿ‡บ๐Ÿ‡ธ USA